Oral vitamin K reversed warfarin-associated coagulopathy faster than subcutaneous vitamin K
- Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy Randomized, Controlled Trial. Crowther, Mark A.; Douketis, James D.; Schnurr, Terri; Steidl, Luigi; Mera, Valentina; Ultori, Carolina; Venco, Achille; Ageno, Walter // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, p251
Presents a study regarding the use of oral vitamin K. Focuses on whether oral vitamin K is more effective than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy; Summaries the results of randomized controlled trial of 26 patients.
- Vitamin K Reverses Overanticoagulation with Warfarin More Quickly When Given by Mouth Than by Injection. // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, pI-39
Presents a summary of the study on the effectiveness of Vitamin K in the treatment of warfarin-associated coagulopathy. Objective of the research; Findings of the researchers; Limitations and implications of the study.
- Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin. Rondina, Matthew // ACP Journal Club;6/23/2009, Vol. 150 Issue 6, p7
The article discusses whether oral vitamin K reduces risk for bleeding in patients with warfarin-associated coagulopathy. A randomized placebo-controlled trial was carried out in 14 anticoagulant centers in the U.S., Canada and Italy. The intervention, outcomes and patient follow up of the trial...
- VITAMIN K & WARFARIN. Barclay, Laurie // Life Extension;Jun2007, Vol. 13 Issue 6, p58
The article discusses the health benefits given by vitamin K, a fat soluble vitamin that helps the proper regulation of blood clotting and optimal bone and cardiovascular health. Vitamin K facilitates the control of anticoagulation therapy in patients on long-term treatment with the...
- Warfarin induced coagulopathy in children: assessment of a conservative approach. Bauman, M. E.; Black, K.; Bauman, M. L.; Kuhle, S.; Bajzar, L.; Massicotte, M. P. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Feb2011, Vol. 96 Issue 2, p164
Background Increasing numbers of children are being administered warfarin therapy as thromboprophylaxis. Warfarin has a narrow therapeutic window with a target international normalised ratio (INR) of 2-3.5, called the therapeutic range. The length of time a patient's INR remains within the...
- Warfarin Overdose: A 25-Year Experience. Levine, Michael; Pizon, Anthony; Padilla-Jones, Angela; Ruha, Anne-Michelle // Journal of Medical Toxicology;Jun2014, Vol. 10 Issue 2, p156
Warfarin, a vitamin K antagonist, is widely used for the prophylaxis and treatment of thromboembolic disease. While guidelines exist for management of a supratherapeutic international normalized ratio following therapeutic warfarin use, these guidelines are not designed for management of the...
- It's in the blood. Allen, Leanne // Nursing Standard;7/7/2004, Vol. 18 Issue 43, p26
Provides information about warfarin therapy. Treatment of acquired clotting disorder; Interaction of warfarin with other drugs; Characteristics of Von Willebrand's disease; Physiological role of vitamin K in the treatment of bleeding.
- Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. Crowther, Mark A.; Ageno, Walter; Garcia, David; Luqi Wang; Witt, Dan M.; Clark, Nathan P.; Blostein, Mark D.; Kahn, Susan R.; Vesely, Sara K.; Schulman, Sam; Kovacs, Michael J.; Rodger, Marc A.; Wells, Phillip; Anderson, David; Ginsberg, Jeffery; Selby, Rita; Siragusa, Sergio; Silingardi, Mauro; Dowd, Mary Beth; Kearon, Clive // Annals of Internal Medicine;3/3/2009, Vol. 150 Issue 5, p293
Background: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain. Objective: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients...
- Oral Vitamin K Corrects Warfarin Coagulopathy. Walling, Anne D. // American Family Physician;5/1/2001, Vol. 63 Issue 9, p1850
Discusses research on the effectiveness of vitamin K in treating warfarin-induced coagulopathy. Reference to a study led by M.A. Crowther which appeared in the November 4, 2000 issue of `Lancet'; Comparison between the active and passive approaches to treatment of warfarin-induced coagulopathy;...